Global Duchenne Muscular Dystrophy Market Analysis 2016-2020 and Forecast 2021-2026

  • Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.

    The global Duchenne Muscular Dystrophy market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Duchenne Muscular Dystrophy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Deflazacort

    Prednisone

    Others

    Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

    PTC Therapeutics

    Sarepta Therapeutics

    Bristol-Myers Squibb

    ITALFARMACO

    BioMarin

    Daiichi Sankyo

    Solid Biosciences

    Summit Therapeutics

    FibroGen

    NS Pharma

    Pfizer

    ReveraGen BioPharma

    Wave Life

    Genethon

    Santhera Pharmaceuticals

    Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

    Male

    Female

    Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

    North America (U.S., Canada, Mexico)

    Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

    Asia-Pacific (China, India, Japan, Southeast Asia etc.)

    South America (Brazil, Argentina etc.)

    Middle East & Africa (Saudi Arabia, South Africa etc.)

     

  • With tables and figures helping analyze worldwide Global Duchenne Muscular Dystrophy market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


    1 Industry Overview

    1.1 Duchenne Muscular Dystrophy Industry

    Figure Duchenne Muscular Dystrophy Industry Chain Structure
    1.1.1 Overview
    1.1.2 Development of Duchenne Muscular Dystrophy

    1.2 Market Segment

    1.2.1 Upstream
    Table Upstream Segment of Duchenne Muscular Dystrophy
    1.2.2 Downstream
    Table Application Segment of Duchenne Muscular Dystrophy
    Table Global Duchenne Muscular Dystrophy Market 2016-2026, by Application, in USD Million
    1.2.3 COVID-19 Impact

    1.3 Cost Analysis


    2 Industry Environment (PEST Analysis)

    2.1 Policy

    2.2 Economics

    2.3 Sociology

    2.4 Technology


    3 Duchenne Muscular Dystrophy Market by Type

    3.1 By Type

    3.1.1 Deflazacort
    Table Major Company List of Deflazacort
    3.1.2 Prednisone
    Table Major Company List of Prednisone
    3.1.3 Others
    Table Major Company List of Others

    3.2 Market Size

    Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in USD Million
    Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in USD Million
    Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in Volume
    Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in Volume

    3.3 Market Forecast

    Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in USD Million
    Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in Volume

    4 Major Companies List

    4.1 PTC Therapeutics (Company Profile, Sales Data etc.)

    4.1.1 PTC Therapeutics Profile
    Table PTC Therapeutics Overview List
    4.1.2 PTC Therapeutics Products & Services
    4.1.3 PTC Therapeutics Business Operation Conditions
    Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.2 Sarepta Therapeutics (Company Profile, Sales Data etc.)

    4.2.1 Sarepta Therapeutics Profile
    Table Sarepta Therapeutics Overview List
    4.2.2 Sarepta Therapeutics Products & Services
    4.2.3 Sarepta Therapeutics Business Operation Conditions
    Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.3 Bristol-Myers Squibb (Company Profile, Sales Data etc.)

    4.3.1 Bristol-Myers Squibb Profile
    Table Bristol-Myers Squibb Overview List
    4.3.2 Bristol-Myers Squibb Products & Services
    4.3.3 Bristol-Myers Squibb Business Operation Conditions
    Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.4 ITALFARMACO (Company Profile, Sales Data etc.)

    4.4.1 ITALFARMACO Profile
    Table ITALFARMACO Overview List
    4.4.2 ITALFARMACO Products & Services
    4.4.3 ITALFARMACO Business Operation Conditions
    Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.5 BioMarin (Company Profile, Sales Data etc.)

    4.5.1 BioMarin Profile
    Table BioMarin Overview List
    4.5.2 BioMarin Products & Services
    4.5.3 BioMarin Business Operation Conditions
    Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.6 Daiichi Sankyo (Company Profile, Sales Data etc.)

    4.6.1 Daiichi Sankyo Profile
    Table Daiichi Sankyo Overview List
    4.6.2 Daiichi Sankyo Products & Services
    4.6.3 Daiichi Sankyo Business Operation Conditions
    Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.7 Solid Biosciences (Company Profile, Sales Data etc.)
    4.7.1 Solid Biosciences Profile
    Table Solid Biosciences Overview List
    4.7.2 Solid Biosciences Products & Services
    4.7.3 Solid Biosciences Business Operation Conditions
    Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.8 Summit Therapeutics (Company Profile, Sales Data etc.)
    4.8.1 Summit Therapeutics Profile
    Table Summit Therapeutics Overview List
    4.8.2 Summit Therapeutics Products & Services
    4.8.3 Summit Therapeutics Business Operation Conditions
    Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.9 FibroGen (Company Profile, Sales Data etc.)
    4.9.1 FibroGen Profile
    Table FibroGen Overview List
    4.9.2 FibroGen Products & Services
    4.9.3 FibroGen Business Operation Conditions
    Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.10 NS Pharma (Company Profile, Sales Data etc.)

    4.10.1 NS Pharma Profile
    Table NS Pharma Overview List
    4.10.2 NS Pharma Products & Services
    4.10.3 NS Pharma Business Operation Conditions
    Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.11 Pfizer (Company Profile, Sales Data etc.)
    4.11.1 Pfizer Profile
    Table Pfizer Overview List
    4.11.2 Pfizer Products & Services
    4.11.3 Pfizer Business Operation Conditions
    Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.12 ReveraGen BioPharma (Company Profile, Sales Data etc.)
    4.12.1 ReveraGen BioPharma Profile
    Table ReveraGen BioPharma Overview List
    4.12.2 ReveraGen BioPharma Products & Services
    4.12.3 ReveraGen BioPharma Business Operation Conditions
    Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
    4.13 Wave Life (Company Profile, Sales Data etc.)
    4.13.1 Wave Life Profile
    Table Wave Life Overview List
    4.13.2 Wave Life Products & Services
    4.13.3 Wave Life Business Operation Conditions
    Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.14 Genethon (Company Profile, Sales Data etc.)
    4.14.1 Genethon Profile
    Table Genethon Overview List
    4.14.2 Genethon Products & Services
    4.14.3 Genethon Business Operation Conditions
    Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
    4.15 Santhera Pharmaceuticals (Company Profile, Sales Data etc.)
    4.15.1 Santhera Pharmaceuticals Profile
    Table Santhera Pharmaceuticals Overview List
    4.15.2 Santhera Pharmaceuticals Products & Services
    4.15.3 Santhera Pharmaceuticals Business Operation Conditions
    Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

    5 Market Competition

    5.1 Company Competition

    Table Global Duchenne Muscular Dystrophy Sales Revenue 2016-2020, by Company, in USD Million
    Table Global Duchenne Muscular Dystrophy Sales Revenue Share 2016-2020, by Company, in USD Million
    Figure Global Duchenne Muscular Dystrophy Sales Revenue Share in 2020, by Company, in USD Million
    Table Global Duchenne Muscular Dystrophy Sales Volume 2016-2020, by Company, in Volume
    Table Global Duchenne Muscular Dystrophy Sales Volume Share 2016-2020, by Company, in Volume
    Figure Global Duchenne Muscular Dystrophy Sales Volume Share in 2020, by Company, in Volume

    5.2 Regional Market by Company

    Figure North America Duchenne Muscular Dystrophy Market Concentration, in 2020
    Figure Europe Duchenne Muscular Dystrophy Market Market Concentration, in 2020
    Figure Asia-Pacific Duchenne Muscular Dystrophy MMarket Concentration, in 2020
    Figure South America Duchenne Muscular Dystrophy Market Concentration, in 2020
    Figure Middle East & Africa Duchenne Muscular Dystrophy Market Concentration, in 2020

    6 Demand by End Market

    6.1 Demand Situation

    6.1.1 Demand in Male
    Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in USD Million
    Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in Volume
    6.1.2 Demand in Female
    Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in USD Million
    Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in Volume

    6.2 Regional Demand Comparison

    Table Regional Demand Comparison List
    Table Major Application in Different Regions

    6.3 Demand Forecast

    Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in USD Million
    Figure Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in USD Million
    Figure Duchenne Muscular Dystrophy Market Share in 2026, by Application, in USD Million
    Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in Volume
    Table Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in Volume
    Table Duchenne Muscular Dystrophy Market Share in 2026, by Application, in Volume

    6.4 Impact of the COVID-19 on the Demand


    7 Region Operation

    7.1 Regional Production

    Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in USD Million
    Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in Volume

    7.2 Regional Market

    Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in USD Million
    Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in USD Million
    Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in Volume
    Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in Volume

    7.3 by Region

    7.3.1 North America
    7.3.1.1 Overview
    Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
    Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
    Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
    Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
    7.3.2 Europe
    7.3.2.1 Overview
    Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
    Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
    Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
    Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
    7.3.3 Asia-Pacific
    7.3.3.1 Overview
    Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
    Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
    Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
    Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
    7.3.4 South America
    7.3.4.1 Overview
    Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
    Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
    Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
    Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
    7.3.5 Middle East & Africa
    7.3.5.1 Overview
    Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
    Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
    Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
    Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume

    7.4 Regional Import & Export

    7.5 Regional Forecast

    Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in USD Million
    Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in Volume

    8 Marketing & Price

    8.1 Price and Margin

    8.1.1 Price Trends
    8.1.2 Factors of Price Change
    Table Price Factors List
    8.1.3 Manufacturers Gross Margin Analysis

    8.2 Marketing Channel

    Figure Marketing Channels Overview

    9 Research Conclusion

     

  • The Global Duchenne Muscular Dystrophy Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Frequently asked questions(FAQ's):
          What gaps and opportunities are seen in the Global Duchenne Muscular Dystrophy Market?

          The flow of investment into the Global Duchenne Muscular Dystrophy Market, which is utilizing technologies to drive efficiency and high volume, clearly shows the market opportunity.

          What are the major applications of the Global Duchenne Muscular Dystrophy Market?

          Depending upon the type of applications, the Global Duchenne Muscular Dystrophy Market has been segmented into and other applications.

          What years are taken into account in the Global Duchenne Muscular Dystrophy Market study?

          The Global Duchenne Muscular Dystrophy Market study evaluates the year spans as follows: Historical year: 2018 to 2023; Base year: 2023; Forecast period**: 2024 to 2029 [** unless otherwise stated]

          What is really changing the Global Duchenne Muscular Dystrophy Market behavior?

          Consumer behavior changes will reshape the entire decision-making process and companies in the Global Duchenne Muscular Dystrophy Industry will need to adapt quickly.

          How is the Global Duchenne Muscular Dystrophy Market's changing dynamics captured?

          The Global Duchenne Muscular Dystrophy analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.

          Our Clients